Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Verfaillie, Catherine  [Clear All Filters]
2024
Zhu Y, Burg T, Neyrinck K, Vervliet T, Nami FA, Vervoort E, Ahuja K, Sassano MLivia, Chai YChin, Tharkeshwar AKumar, et al. Disruption of MAM integrity in mutant FUS oligodendroglial progenitors from hiPSCs. Acta Neuropathol. 2024;147(1):6.
Chandrasekaran V, Wellens S, Bourguignon A, Djidrovski I, Fransen L, Ghosh S, Mazidi Z, Murphy C, Nunes C, Singh P, et al. Evaluation of the impact of iPSC differentiation protocols on transcriptomic signatures. Toxicol In Vitro. 2024:105826.
Decoene I, Nasello G, de Costa RFurtado Ma, Hall GNilsson, Pastore A, Van Hoven I, Viseu SRibeiro, Verfaillie C, Geris L, Luyten FP, et al. Robotics-Driven Manufacturing of Cartilaginous Microtissues for Skeletal Tissue Engineering Applications. Stem Cells Transl Med. 2024.
2023
Zaunz S, De Smedt J, Lauwereins L, Cleuren L, Laffeber C, Bajaj M, Lebbink JHG, Marteijn JA, De Keersmaecker K, Verfaillie C. APEX1 Nuclease and Redox Functions are Both Essential for Adult Mouse Hematopoietic Stem and Progenitor Cells. Stem Cell Rev Rep. 2023.
Tiane A, Schepers M, Reijnders RA, van Veggel L, Chenine S, Rombaut B, Dempster E, Verfaillie C, Wasner K, Grünewald A, et al. From methylation to myelination: epigenomic and transcriptomic profiling of chronic inactive demyelinated multiple sclerosis lesions. Acta Neuropathol. 2023.
Grebenyuk S, Fattah ARahman Abd, Kumar M, Toprakhisar B, Rustandi G, Vananroye A, Salmon I, Verfaillie C, Grillo M, Ranga A. Large-scale perfused tissues via synthetic 3D soft microfluidics. Nat Commun. 2023;14(1):193.
Athanasouli P, Balli M, De Jaime-Soguero A, Boel A, Papanikolaou S, van der Veer BK, Janiszewski A, Vanhessche T, Francis A, Laithy YEl, et al. The Wnt/TCF7L1 transcriptional repressor axis drives primitive endoderm formation by antagonizing naive and formative pluripotency. Nat Commun. 2023;14(1):1210.
2022
Nunes C, Singh P, Mazidi Z, Murphy C, Bourguignon A, Wellens S, Chandrasekaran V, Ghosh S, Zana M, Pamies D, et al. An in vitro strategy using multiple human induced pluripotent stem cell-derived models to assess the toxicity of chemicals: A case study on paraquat. Toxicol In Vitro. 2022:105333.
Moreno-Torres M, Kumar M, García-Llorens G, Quintás G, Tricot T, Boon R, Tolosa L, Toprakhisar B, Chesnais F, Verfaillie C, et al. A Novel UPLC-MS Metabolomic Analysis-Based Strategy to Monitor the Course and Extent of iPSC Differentiation to Hepatocytes. J Proteome Res. 2022.
Kwok CKeong, Sébastien I, Hariharan K, Meiser I, Wihan J, Altmaier S, Karnatz I, Feile A, Cabrera-Socorro A, Rasmussen M, et al. Scalable expansion of iPSC and their derivatives across multiple lineages. Reprod Toxicol. 2022.
Cuyx S, Ramalho SS, Callebaut I, Cuppens H, Kmit A, Arnauts K, Ferrante M, Verfaillie C, Ensinck M, Carlon MS, et al. Severity of the S1251N allele in cystic fibrosis is affected by the presence of the F508C variant in cis. J Cyst Fibros. 2022.
2021
De Boeck J, Verfaillie C. Doxycycline inducible overexpression systems: how to induce your gene of interest without inducing misinterpretations. Mol Biol Cell. 2021;32(17):1517-1522.
Braak BTer, Niemeijer M, Boon R, Parmentier C, Baze A, Richert L, Huppelschoten S, Wink S, Verfaillie C, van de Water B. Systematic transcriptome-based comparison of cellular adaptive stress response activation networks in hepatic stem cell-derived progeny and primary human hepatocytes. Toxicol In Vitro. 2021:105107.
2019
Desiderio S, Vermeiren S, Van Campenhout C, Kricha S, Malki E, Richts S, Fletcher EV, Vanwelden T, Schmidt BZ, Henningfeld KA, et al. Prdm12 Directs Nociceptive Sensory Neuron Development by Regulating the Expression of the NGF Receptor TrkA. Cell Rep. 2019;26(13):3522-3536.e5.
2018
Roy IM, Biswas A, Verfaillie C, Khurana S. Energy Producing Metabolic Pathways in Functional Regulation of the Hematopoietic Stem Cells. IUBMB Life. 2018;70(7):612-624.
2016
Hoornaert CJ, Luyckx E, Reekmans K, Dhainaut M, Guglielmetti C, Le Blon D, Dooley D, Fransen E, Daans J, Verbeeck L, et al. In vivo IL13-primed macrophages contribute to reduced alloantigen-specific T cell activation and prolong immunological survival of allogeneic mesenchymal stem cell implants. Stem Cells. 2016.